List of Tables
    Table 1. Antacids CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Antacids Market Trends
    Table 3. Antacids Market Drivers
    Table 4. Antacids Market Challenges
    Table 5. Antacids Market Restraints
    Table 6. Global Antacids Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Antacids Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Antacids Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Antacids Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Antacids Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Antacids Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Antacids Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Antacids Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Antacids Sales Share by Manufacturer, 2017-2022
    Table 15. Global Antacids Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Antacids Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Antacids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antacids as of 2021)
    Table 18. Top Players of Antacids in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Antacids Product Type
    Table 20. Date of International Manufacturers Enter into Antacids Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Antacids Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Antacids Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Antacids Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Antacids Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Antacids Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Antacids Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Antacids Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Antacids Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Antacids Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Antacids Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Antacids Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Antacids Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Antacids Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Antacids Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Antacids Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Antacids Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Antacids Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Antacids Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Antacids Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Antacids Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. AstraZeneca Corporation Information
    Table 43. AstraZeneca Description and Business Overview
    Table 44. AstraZeneca Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. AstraZeneca Antacids Product
    Table 46. AstraZeneca Recent Development
    Table 47. Takeda Pharmaceutical Corporation Information
    Table 48. Takeda Pharmaceutical Description and Business Overview
    Table 49. Takeda Pharmaceutical Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Takeda Pharmaceutical Product
    Table 51. Takeda Pharmaceutical Recent Development
    Table 52. Pfizer Corporation Information
    Table 53. Pfizer Description and Business Overview
    Table 54. Pfizer Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Pfizer Product
    Table 56. Pfizer Recent Development
    Table 57. Reckitt Benckiser Corporation Information
    Table 58. Reckitt Benckiser Description and Business Overview
    Table 59. Reckitt Benckiser Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Reckitt Benckiser Product
    Table 61. Reckitt Benckiser Recent Development
    Table 62. Bayer Corporation Information
    Table 63. Bayer Description and Business Overview
    Table 64. Bayer Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Bayer Product
    Table 66. Bayer Recent Development
    Table 67. Procter & Gamble Corporation Information
    Table 68. Procter & Gamble Description and Business Overview
    Table 69. Procter & Gamble Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Procter & Gamble Product
    Table 71. Procter & Gamble Recent Development
    Table 72. GlaxoSmithKline Corporation Information
    Table 73. GlaxoSmithKline Description and Business Overview
    Table 74. GlaxoSmithKline Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. GlaxoSmithKline Product
    Table 76. GlaxoSmithKline Recent Development
    Table 77. Johnson & Johnson Corporation Information
    Table 78. Johnson & Johnson Description and Business Overview
    Table 79. Johnson & Johnson Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Johnson & Johnson Product
    Table 81. Johnson & Johnson Recent Development
    Table 82. CONBA Corporation Information
    Table 83. CONBA Description and Business Overview
    Table 84. CONBA Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. CONBA Product
    Table 86. CONBA Recent Development
    Table 87. Xiuzheng Pharma Corporation Information
    Table 88. Xiuzheng Pharma Description and Business Overview
    Table 89. Xiuzheng Pharma Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Xiuzheng Pharma Product
    Table 91. Xiuzheng Pharma Recent Development
    Table 92. Sanofi Corporation Information
    Table 93. Sanofi Description and Business Overview
    Table 94. Sanofi Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Sanofi Product
    Table 96. Sanofi Recent Development
    Table 97. Bausch Health Corporation Information
    Table 98. Bausch Health Description and Business Overview
    Table 99. Bausch Health Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. Bausch Health Product
    Table 101. Bausch Health Recent Development
    Table 102. CR SANJIU Corporation Information
    Table 103. CR SANJIU Description and Business Overview
    Table 104. CR SANJIU Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 105. CR SANJIU Product
    Table 106. CR SANJIU Recent Development
    Table 107. Novartis Corporation Information
    Table 108. Novartis Description and Business Overview
    Table 109. Novartis Antacids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 110. Novartis Product
    Table 111. Novartis Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Antacids Customers List
    Table 115. Antacids Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antacids Product Picture
    Figure 2. Global Antacids Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Antacids Market Size 2017-2028 (US$ Million)
    Figure 4. Global Antacids Sales 2017-2028 (K Units)
    Figure 5. United States Antacids Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Antacids Market Size 2017-2028 (US$ Million)
    Figure 7. United States Antacids Sales 2017-2028 (K Units)
    Figure 8. United States Antacids Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Antacids Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Antacids Report Years Considered
    Figure 11. Product Picture of Non-Systemic Antacids
    Figure 12. Product Picture of Systemic Antacids
    Figure 13. Global Antacids Market Share by Type in 2022 & 2028
    Figure 14. Global Antacids Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Antacids Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Antacids Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Antacids Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Antacids Price by Type (2017-2028) & (US$/Unit)
    Figure 19. United States Antacids Market Share by Type in 2022 & 2028
    Figure 20. United States Antacids Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Antacids Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Antacids Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Antacids Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Antacids Price by Type (2017-2028) & (US$/Unit)
    Figure 25. Product Picture of Rx Drug
    Figure 26. Product Picture of OTC Drug
    Figure 27. Global Antacids Market Share by Application in 2022 & 2028
    Figure 28. Global Antacids Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Antacids Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Antacids Sales by Application (2017-2028) & (K Units)
    Figure 31. Global Antacids Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Antacids Price by Application (2017-2028) & (US$/Unit)
    Figure 33. United States Antacids Market Share by Application in 2022 & 2028
    Figure 34. United States Antacids Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Antacids Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Antacids Sales by Application (2017-2028) & (K Units)
    Figure 37. United States Antacids Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Antacids Price by Application (2017-2028) & (US$/Unit)
    Figure 39. North America Antacids Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 40. North America Antacids Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Antacids Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. Europe Antacids Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Antacids Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 51. Asia-Pacific Antacids Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Antacids Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Antacids Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Antacids Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa Antacids Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. U.A.E Antacids Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Antacids Value Chain
    Figure 73. Antacids Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed